£80.66

Springer Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Price data last checked 16 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£81 today · all-time low £81 (May 2026) · usually £81

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical
Generating forecast…
£84.29 £80.28 £81.15 £82.03 £82.90 £83.78 £84.66 26 April 2026 14 May 2026 02 June 2026 20 June 2026 09 July 2026

Price Distribution

Price distribution over 75 days • 2 price levels

Days at Price
Current Price
70 days · current 5 days 0 18 35 53 70 £81 £84 Days at Price

Price Analysis

Most common price: £81 (70 days, 93.3%)

Price range: £81 - £84

Price levels: 2 different prices over 75 days

Description

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life. From the Back Cover Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide means that multiple myeloma now stands at the forefront of advances in oncology drug development. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
98% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.24 12 Jun 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
98% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£79.19 06 May 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 11 Jun 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
98% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.98 05 May 2026
Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)
98% match

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

CRC Press

£84.74 18 Jul 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
98% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 02 Jul 2026
Treatment of Multiple Myeloma and Related Disorders
98% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 04 Jul 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
98% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.08 03 Jul 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
98% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Academic Press

£168.99 19 Jun 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
97% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£150.17 12 Jun 2026
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
97% match

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Springer

£104.34 20 Jul 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.10 17 Jul 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£248.00 17 Jun 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
97% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.32 10 Jul 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
97% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£85.77 23 Jul 2026
Consulting Hematology and Oncology Handbook
97% match

Consulting Hematology and Oncology Handbook

Springer

£54.69 08 Jul 2026
Clinical Malignant Hematology
97% match

Clinical Malignant Hematology

McGraw-Hill Education

£201.99 17 Jun 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
97% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£62.16 08 Jul 2026
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
97% match

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Springer

£113.76 16 Jul 2026
Myeloma Bone Disease (Current Clinical Oncology)
96% match

Myeloma Bone Disease (Current Clinical Oncology)

Humana

£140.26 02 Jul 2026
Horizons in Cancer Research. Volume 73: Volume 73
96% match

Horizons in Cancer Research. Volume 73: Volume 73

£113.87 13 Jun 2026
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
96% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£109.99 12 Jun 2026
Oxford Textbook of Neurohaematology (Oxford Textbooks in Clinical Neurology)
96% match

Oxford Textbook of Neurohaematology (Oxford Textbooks in Clinical Neurology)

Oxford University Press

£143.92 18 Jun 2026
Hematologic Malignancies: Methods and Techniques: 55 (Methods in Molecular Medicine, 55)
96% match

Hematologic Malignancies: Methods and Techniques: 55 (Methods in Molecular Medicine, 55)

Humana

£73.13 11 Jul 2026